Osaic Holdings
RGC icon

Osaic Holdings’s Regencell Bioscience RGC Stock Holding History

Osaic Holdings’s Portfolio RGC Stock Details RGC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.77K Hold
227
– – ﹤0.01% 6612
2025
Q4 		$4.77K Hold
227
– – ﹤0.01% 6729
2025
Q3 		$3.27K Buy
227
+37
+19% +$531 ﹤0.01% 6961
2025
Q2 		$3.24K Buy
+190
New +$2.32K ﹤0.01% 6767

Other funds holding RGC

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MG
Marex Group London $15.8B AUM 31.44% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
VA
Vident Advisory Alpharetta, Georgia $11.7B AUM 37.32% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Osaic Holdings's RGC Position: Q1 2026 in Review

Osaic Holdings held its Regencell Bioscience (RGC) position steady in Q1 2026 at 227 shares worth $5.77K. The position accounts for ﹤0.01% of the portfolio, ranked #6612.

Osaic Holdings first reported a position in RGC in Q2 2025 and has held it in 4 quarters since. 31 funds tracked by Wall St. Rank hold RGC as of Q1 2026.

  • Osaic Holdings held 227 shares of Regencell Bioscience worth $5.77K as of Q1 2026.
  • Osaic Holdings left its Regencell Bioscience share count unchanged in Q1 2026.
  • Regencell Bioscience made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #6612 holding.
  • Osaic Holdings first reported a position in Regencell Bioscience in Q2 2025 and has held it in 4 quarters since.
  • 31 funds tracked by Wall St. Rank held Regencell Bioscience as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.